Renaissance Technologies’s Chembio diagnostics, Inc. CEMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-157,100
| Closed | -$69K | – | 4465 |
|
|
2023
Q1 | $69K | Buy |
157,100
+20,700
| +15% | +$8.11K | ﹤0.01% | 3589 |
|
|
2022
Q4 | $30K | Buy |
136,400
+22,800
| +20% | +$6.82K | ﹤0.01% | 3893 |
|
|
2022
Q3 | $41K | Buy |
113,600
+90,100
| +383% | +$61.5K | ﹤0.01% | 3807 |
|
|
2022
Q2 | $15K | Buy |
+23,500
| New | +$15.6K | ﹤0.01% | 4146 |
|
|
2021
Q3 | – | Sell |
-54,474
| Closed | -$162K | – | 4062 |
|
|
2021
Q2 | $162K | Sell |
54,474
-100,166
| -65% | -$349K | ﹤0.01% | 3290 |
|
|
2021
Q1 | $543K | Buy |
+154,640
| New | +$861K | ﹤0.01% | 2880 |
|
|
2019
Q3 | – | Sell |
-34,500
| Closed | -$210K | – | 3900 |
|
|
2019
Q2 | $210K | Sell |
34,500
-35,800
| -51% | -$241K | ﹤0.01% | 3294 |
|
|
2019
Q1 | $390K | Sell |
70,300
-13,999
| -17% | -$90.9K | ﹤0.01% | 3019 |
|
|
2018
Q4 | $477K | Buy |
84,299
+40,499
| +92% | +$298K | ﹤0.01% | 2880 |
|
|
2018
Q3 | $460K | Buy |
43,800
+22,100
| +102% | +$237K | ﹤0.01% | 2875 |
|
|
2018
Q2 | $241K | Buy |
+21,700
| New | +$195K | ﹤0.01% | 3032 |
|
|
2016
Q3 | – | Sell |
-48,200
| Closed | -$395K | – | 3677 |
|
|
2016
Q2 | $395K | Buy |
48,200
+34,300
| +247% | +$267K | ﹤0.01% | 2865 |
|
|
2016
Q1 | $83K | Buy |
13,900
+800
| +6% | +$4.13K | ﹤0.01% | 3237 |
|
|
2015
Q4 | $70K | Buy |
+13,100
| New | +$65.7K | ﹤0.01% | 3145 |
|
Other funds holding CEMI
Renaissance Technologies's CEMI Position: Q2 2023 in Review
Renaissance Technologies sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2023, closing a stake of 157,100 shares — an estimated $69K sold.
Renaissance Technologies first reported a position in CEMI in Q4 2015 and held it in 14 quarters. The position peaked at $543K in Q1 2021. 1 fund tracked by Wall St. Rank holds CEMI as of Q2 2023.
- Renaissance Technologies reported no remaining Chembio diagnostics, Inc. position as of Q2 2023 after selling out during the quarter.
- Renaissance Technologies sold 157,100 Chembio diagnostics, Inc. shares in Q2 2023, an estimated $69K.
- Renaissance Technologies first reported a position in Chembio diagnostics, Inc. in Q4 2015 and held it in 14 quarters.
- Renaissance Technologies's Chembio diagnostics, Inc. position peaked at $543K in Q1 2021.
- 1 fund tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2023.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.